Rapid MRI for Assessing Functional Abilities and Predicting TBI Outcomes

NCT ID: NCT06454591

Last Updated: 2024-10-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-11-30

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Our project aims to develop a rapidly acquired and communicated MRI assessment and report that incorporates functional and structural imaging to convey information about functional neurological insults following traumatic brain injury (TBI) that are not typically visible on clinical imaging. Within this framework, there are two sub-studies. The first is a prospective study of patients with TBI who will have an MRI in the sub-acute period after their injury, followed by clinical assessments up to 90 days post-injury. A model will be developed to link MRI biomarkers to persistent symptoms of TBI. The second sub-study will use a focus group methodology to develop the report content and format with input from several groups of stakeholders.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Traumatic brain injury (TBI) can range from mild (mTBI) to moderate and severe (msTBI), and 69 million individuals worldwide sustain a TBI annually. There are many unanswered questions related to the diagnosis of TBI, the prediction of recovery, and the selection of effective treatments. For a subset of patients with TBI, persistent symptoms (PS) can substantially reduce quality of life. Particularly for mTBI, these impairments occur frequently without evidence of structural damage to the brain on MRI or CT. The lack of objective evidence of damage can limit a patient's access to clinical resources, insurance coverage and compensation related to their injury.

Furthermore, clinicians often have difficulty predicting TBI patients' course and extent of recovery. Preliminary evidence suggests that combining several novel types of MRI techniques may enable the detection of changes in individuals with TBI and provide information about patient recovery. Therefore, our proposed research project will assess individuals with TBI using novel MRI and a battery of assessments that examine how they function (functional assessments) in the acute stages after injury with a complete reassessment of function three months after injury. These procedures will be performed in 200 patients. Overall, this project will incorporate TBI survivors, family members/caregivers, clinicians, and members of the legal/insurance community to address four goals:

1. To develop reports for survivors and their supporters to communicate MRI and functional assessment findings. This report will help survivors understand their injuries and symptoms and suggest treatments. Additionally, a more technical report will be developed for clinicians and legal/insurance personnel to support diagnosis, direct testing, and aid in choosing therapeutic approaches. Focus groups will be conducted for each group to develop the report content and format.
2. To link MRI findings to neurological function and symptoms. The use of several MRI sequences increases our ability to identify deficits. However, this large amount of information may be difficult for a clinician to review, synthesize and use to predict patient function. The investigators developed a method to summarize the MRI data into intuitive outputs to address this. These outputs are linked to function and allow clinicians and patients to connect the damage detected by MRI to impairments in function.
3. To develop a tool to assess the risk of PS 90 days after injury using MRI and clinical data collected early after injury.
4. To develop a comprehensive MRI protocol that can be performed within the shortest possible time on any clinical MRI scanner to make this testing widely accessible. For the complete MRI protocol used in this study, the total time will be 45 minutes, with five types of MRI collected. The investigators will perform analyses where one or more MRI types is removed from the analysis to understand whether all types collected are necessary to achieve the outcome. This will allow us to reduce the scan time as the clinical protocol is developed.

Findings from this work will be impactful for the following reasons: (1) the development of a report will allow patients and caregivers to be more informed about their path to recovery; (2) the development of an accessible clinical protocol and report will allow clinicians to access functional neuroimaging; (3) a protocol that links functional neuroimaging changes to functional impairment will provide evidence that injury is linked to signs/symptoms in TBI; (4) identification of patients at risk for PS combined with a comprehensive functional evaluation in the acute stages of injury will allow clinicians to focus on early therapy to prevent PS; and (5) development of the shortest possible protocol for data acquisition that increases patient comfort and increases accessibility to functional neuroimaging in the clinical setting.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Traumatic Brain Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TBI patients

No interventions assigned to this group

Individuals with chronic TBI

No interventions assigned to this group

Caregivers of individuals with chronic TBI

No interventions assigned to this group

Clinicians who treat individuals with TBI

No interventions assigned to this group

Legal and insurance personnel

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Diagnosis of TBI


\- Diagnosis of TBI greater than one year prior


\- Relation who was diagnosed with TBI greater than one year prior that individual was the primary caregiver for


\- Employment as a physician or allied health professional who has spent greater than 50% of their time treating TBI patients for at least two years of their career


\- Employment as a personal injury lawyer or insurance adjuster who has spent greater than 50% of their time on TBI cases for at least two years of their career

Exclusion Criteria

* Self-reported history of brain surgery
* Self-reported history of major neurologic, psychiatric or substance use disorder
* Contraindications to MRI
* Inability to follow-up at 30 and 90 days

Focus group study Individuals with chronic TBI


\- Major neurologic, psychiatric or substance use disorder

Caregivers of individuals with chronic TBI


\- Major neurologic, psychiatric or substance use disorder

Clinicians who treat TBI


-N/A


-N/A
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Calgary

OTHER

Sponsor Role collaborator

D.J Cook

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

D.J Cook

Professor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Douglas J Cook, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Queen's University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Calgary

Calgary, Alberta, Canada

Site Status RECRUITING

Queen's University

Kingston, Ontario, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Douglas J Cook, MD, PhD

Role: CONTACT

1-613-549-6666 ext. 3696

Chantel Debert, MD, MSc

Role: CONTACT

1-403-944-4224

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Chantel Debert

Role: primary

4032205110

DJ Cook

Role: primary

61354966666 ext. 3696

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

6041393

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PET-MRI in Chronic Traumatic Brain Injury (CTBI)
NCT03241732 ENROLLING_BY_INVITATION NA
18F-AV-1451 PET Imaging in TBI
NCT02512029 WITHDRAWN PHASE1